Completed

Screening Study for the Evaluation and Diagnosis of Potential Research Subjects With Ocular Inflammatory or Immunologic Diseases

0 criteria met from your profileSee at a glance how your profile meets each eligibility criteria.
What is being collected

Data Collection

Who is being recruted

Conjunctival Diseases+16

+ Corneal Diseases

+ Eye Diseases

Over 2 Years
See all eligibility criteria
How is the trial designed

Observational
Study Start: March 1998
See protocol details

Summary

Principal SponsorNational Eye Institute (NEI)
Last updated: July 2, 2017
Sourced from a government-validated database.Claim as a partner

Study start date: March 23, 1998

Actual date on which the first participant was enrolled.

This protocol is designed for the screening of patients with either diagnosed or undiagnosed conditions, and serves as a first step for individuals who may be eligible, and wish to participate in NEI- National Eye Institute clinical research studies. Each individual will be thoroughly evaluated during the screening process to determine if they are suitable candidates for inclusion in any of the NEI ongoing studies. The screening evaluation will include past and current medical histories, and an appropriate physical examination. Other routine diagnostic procedures and tests may also be completed in order to help determine a subject's eligibility. These tests and procedures are of minimal risk and will be described in more detail in section III: "Study Procedures". Once the screening process is completed and their eligibility is assessed, the subjects will be informed of their options to participate in one or more of the current clinical research studies. If no appropriate protocol is identified, recommendations for other treatment options may be given to the individual, their primary doctor, or referring physician.

NCT00001734
Principal SponsorNational Eye Institute (NEI)
Last updated: July 2, 2017
Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.
Design Details

3000 patients to be enrolled

Total number of participants that the clinical trial aims to recruit.

Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.
Conditions
Criteria

Any sex

Biological sex of participants that are eligible to enroll.

Over 2 Years

Range of ages for which participants are eligible to join.

Healthy volunteers not allowed

If individuals who are healthy and do not have the condition being studied can participate.

Conditions

Pathology

Conjunctival DiseasesCorneal DiseasesEye DiseasesInfectionsIris DiseasesPathologic ProcessesRetinal DiseasesPathological Conditions, Signs and SymptomsUveal DiseasesUveitis, AnteriorEye InfectionsPanuveitisConjunctivitisInflammationIritisKeratitisEndophthalmitisRetinitisUveitis

Criteria

Participants will be able to enroll if they: Have a diagnosed ocular inflammatory eye disease; OR Have an unusual, interesting or unknown ocular condition that requires the establishment of a diagnosis; AND Have the ability to understand and sign an informed consent OR have a legal parent/guardian with the ability to do the same. 2.2 Exclusion Criteria Participants will be unable to enroll if they: Have no ocular medical conditions; OR Are unwilling or unable to cooperate with the procedures.

Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.

This study has 1 location

National Institutes of Health Clinical Center, 9000 Rockville Pike

Bethesda, United StatesOpen National Institutes of Health Clinical Center, 9000 Rockville Pike in Google Maps
CompletedOne Study Center